Figure 3From: Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trialBeta-HCG trends before and after sutent. Arrow points to initiation of sutent.Back to article page